These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 21272626)
1. Porphyrin-containing polyaspartamide gadolinium complexes as potential magnetic resonance imaging contrast agents. Yan GP; Li Z; Xu W; Zhou CK; Yang L; Zhang Q; Li L; Liu F; Han L; Ge YX; Guo JF Int J Pharm; 2011 Apr; 407(1-2):119-25. PubMed ID: 21272626 [TBL] [Abstract][Full Text] [Related]
2. Polyaspartamide gadolinium complexes containing sulfadiazine groups as potential macromolecular MRI contrast agents. Yan GP; Liu ML; Li LY Bioconjug Chem; 2005; 16(4):967-71. PubMed ID: 16029038 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents. Yan GP; Hu B; Liu ML; Li LY J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991 [TBL] [Abstract][Full Text] [Related]
4. Porphyrin-containing Gadolinium Complex as a Tumor-targeting Magnetic Resonance Imaging (MRI) Contrast Agent. Ouyang YH; Xu W; Zhou CK; Liu F; Li B; Yan GP; Yang L; Chen S; Jiang C Curr Drug Deliv; 2018; 15(7):972-978. PubMed ID: 29629659 [TBL] [Abstract][Full Text] [Related]
5. Gadolinium-DTPA enhancement of VX-2 carcinoma of the rabbit kidney on T1 weighted magnetic resonance images. Yancey JM; Ackerman N; Kaude JV; Googe RE; Fitzsimmons JR; Scott KN; Mancuso AA; Hackett RL; Hager DA; Caballero S Acta Radiol; 1987; 28(4):479-82. PubMed ID: 2958067 [TBL] [Abstract][Full Text] [Related]
6. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery]. Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304 [TBL] [Abstract][Full Text] [Related]
7. Diethylenetriaminepentaacetic acid-gadolinium (DTPA-Gd)-conjugated polysuccinimide derivatives as magnetic resonance imaging contrast agents. Lee HY; Jee HW; Seo SM; Kwak BK; Khang G; Cho SH Bioconjug Chem; 2006; 17(3):700-6. PubMed ID: 16704207 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent. Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209 [TBL] [Abstract][Full Text] [Related]
9. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging. Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653 [TBL] [Abstract][Full Text] [Related]
10. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics. Burai L; Tóth E; Sour A; Merbach AE Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439 [TBL] [Abstract][Full Text] [Related]
11. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy. Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573 [TBL] [Abstract][Full Text] [Related]
12. [Preoperative staging of bladder carcinomas with Gd-DTPA-supported dynamic magnetic resonance tomography. Comparison with plain and Gd-DTPA-supported spin-echo sequences]. Venz S; Hosten N; Ilg J; Mäurer J; Podrabsky P; Fedel M; Ebert T; Nagel R Rofo; 1996 Mar; 164(3):218-25. PubMed ID: 8672777 [TBL] [Abstract][Full Text] [Related]
14. Gadolinium-DTPA enhancement of experimental soft tissue carcinoma and hemorrhage in magnetic resonance imaging. Pettersson H; Ackerman N; Kaude J; Googe RE; Mancuso AA; Scott KN; Hackett RH; Hager DA; Caballero S Acta Radiol; 1987; 28(1):75-8. PubMed ID: 2952147 [TBL] [Abstract][Full Text] [Related]
15. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
16. Dextran gadolinium complexes as contrast agents for magnetic resonance imaging to sentinel lymph nodes. Yan GP; Xu W; Yang L; Li L; Liu F; Guo QZ Pharm Res; 2010 Sep; 27(9):1884-92. PubMed ID: 20559699 [TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis. Hamm B; Laniado M; Saini S Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422 [TBL] [Abstract][Full Text] [Related]
18. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739 [TBL] [Abstract][Full Text] [Related]
19. Development of a conjugated gadolinium and cisplatin-gelatin possessing properties as an intravascular contrast agent for MR imaging. Sonoda A; Nitta N; Ohta S; Seko A; Jo J; Morikawa S; Tabata Y; Takahashi M; Murata K Eur J Radiol; 2009 Sep; 71(3):570-5. PubMed ID: 18502598 [TBL] [Abstract][Full Text] [Related]
20. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]